Sirio Pharma Co., Ltd. (SHE:300791)

China flag China · Delayed Price · Currency is CNY
23.97
-0.24 (-0.99%)
Sep 26, 2025, 3:04 PM CST
-0.99%
Market Cap7.33B
Revenue (ttm)4.26B
Net Income (ttm)331.71M
Shares Out305.65M
EPS (ttm)1.09
PE Ratio22.01
Forward PE20.03
Dividend0.50 (2.09%)
Ex-Dividend DateMay 27, 2025
Volume1,679,025
Average Volume3,653,152
Open24.19
Previous Close24.21
Day's Range23.81 - 24.35
52-Week Range16.32 - 28.19
Beta0.43
RSI45.21
Earnings DateOct 24, 2025

About Sirio Pharma

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China. [Read more]

Founded 1993
Employees 2,776
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300791
Full Company Profile

Financial Performance

In 2024, Sirio Pharma's revenue was 4.21 billion, an increase of 17.56% compared to the previous year's 3.58 billion. Earnings were 325.06 million, an increase of 15.66%.

Financial Statements

News

There is no news available yet.